Interferon

Type: Keyphrase
Name: Interferon
First reported 46 mins ago - Updated 46 mins ago - 1 reports

Study Modification: Response to interferon beta therapy

AUTHOR: Byun ESTUDY DATE: January 14, 2008TITLE: Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. ... [Published National Human Genome Research Institute - 46 mins ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

The Market Will Demand a Cheaper Alternative to Sovaldi

A new report from Frost & Sullivan forecasts “robust demand” for HCV antivirals, with several strong competitors “maneuvering aggressively” to narrow the market gap by introducing a treatment that can outdo Gilead’s Sovaldi.But as the market moves away ... [Published Pharmaceutical Executive - 6 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

AWMSG decisions

The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): eltrombopag to treat thrombocytopenia in adults with hepatitis C infection where the degree of thrombocytopenia is compromising the efficacy ... [Published Pharmaceutical Journal - 8 hours ago]
First reported Jul 29 2014 - Updated 11 hours ago - 1 reports

Illinois Medicaid restricts who can get 'game-changing' hepatitis drug

Following the lead of other states, Illinois Medicaid officials have put in place tight criteria on prescriptions for Sovaldi, a new drug for hepatitis C with potentially game-changing effectiveness, but also a budget-breaking price tag.A panel at the ... [Published Crains ChicagoBusiness - Jul 29 2014]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon

Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for ... [Published Free Patents Online - 18 hours ago]
Entities: Interferon, Molecule, RNA
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Interfering with interferon -- ScienceDaily

Using the body's natural virus killers to prevent and treat HIV infection has been problematic until now because of the strong inflammatory response these molecules can arouse as they get rid of the invaders. Now, collaborative research conducted by scientists ... [Published DailyMe.Com - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Today in Science: GLV Daily Digest for July 28, 2014

Today in science, a mathematical model may be able to explain infertility, and the secret is sex-specific genes. Mayflies are swarming out of the Mississippi in such great numbers that they have already caused a three-vehicle car accident. A new study ... [Published The Guardian Express - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune ...

Experimental autoimmune encephalomyelitis (EAE) is an animal model of autoimmune inflammatory demyelination that is mediated by Th1 and Th17 cells. The transcription factor interferon regulatory factor 3 (IRF3) is activated by pathogen recognition receptors ... [Published 7thSpace - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 5 reports

New therapies for HCV create better alternatives for patients

Therapeutic advances in treating hepatitis C virus have greatly increased a patient’s chance for a cure and at a faster rate, according to a consumer update from the FDA.The new report, available on the FDA website, states that interferon injections were ... [Published Orthopedics Today - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 3 reports

COSMOS Results Published on World Hepatitis Day

Medivir AB announced that results from the phase 2 COSMOS clinical study were published in The Lancet , demonstrating that 92% of genotype 1 chronic hepatitis C virus adult patients treated with simeprevir in combination with sofosbuvir achieved sustained ... [Published Drug Discovery and Development - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 2 reports

Interfering with interferon

Using the body's natural virus killers to prevent and treat HIV infection has been problematic until now because of the strong inflammatory response these molecules can arouse as they get rid of the invaders. Now, collaborative research conducted by scientists ... [Published Bio-Medicine - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Will BC Cover Pricey Hep C 'Miracle' Treatment?

Patients have waited decades for such a 'finite cure,' but most can't pay for it.For most of the roughly 242,500 people in Canada with hep C, a cure is possible, but not yet in reach. Drug photo via Shutterstock.Hepatitis C patients in B.C. are waiting ... [Published TheTyee.ca - Jul 28 2014]
Entities: Interferon, Drugs, Medicaid

Quotes

"Our Life Science businesses, in particular, saw unabated growth momentum, with very encouraging sales gains for our recently launched pharmaceutical products and our North and Latin American CropScience business" said management board chairman Marijn Dekkers...
Besides this Keynote forum, this three day event is scheduled to organize significant sessions like Speaker session and International symposium like "Aptamers for the detection of cytokines and their potential as cytokine inhibitors” and “Interferons and their role in autoimmune diseases”. With a strong intent to encourage the Young investigators and Post Doctoral Fellows, Immunology Summit-2014 is also hosting exclusive sessions like: Young Research Forum etc.. “Best poster awards” will be awarded during the poster session basis on the quality of the research work, Novelty and quality of representation."
...Harrigan says. "These newer therapies are completely changing the landscape of hepatitis C treatment."
...to the hybridization of nucleic acids is found in Tijssen, Techniques in Biochemistry and Molecular Biology--Hybridization with Nucleic Probes, "Overview of principles of hybridization and the strategy of nucleic acid assays" (1993). Generally, highly stringent conditions are selected to be about 5-10.degree. C lower than the thermal melting point (T.sub...

More Content

All (636) | News (482) | Reports (0) | Blogs (147) | Audio/Video (0) | Fact Sheets (3) | Press Releases (2)
sort by: Date | Relevance
Study Modification: Response to interferon beta... [Published National Human Genome Research Institute - 46 mins ago]
Bayer’s 2nd-qtr earnings hit by currency, missi... [Published Pharma Letter - 2 hours ago]
New hepatitis C treatment show 90% cure rate [Published Consumer Affairs - 4 hours ago]
The Market Will Demand a Cheaper Alternative to... [Published Pharmaceutical Executive - 6 hours ago]
AWMSG decisions [Published Pharmaceutical Journal - 8 hours ago]
Unveiling Breakthroughs in Clinical & Cellular ... [Published PRWeb - 10 hours ago]
UBC develops test to ensure effectiveness of ne... [Published Noodls - 15 hours ago]
CA9 gene single nucleotide polymorphisms predic... [Published PharmCast - 17 hours ago]
Double-stranded and single-stranded RNA molecul... [Published Free Patents Online - 18 hours ago]
Can Biogen Idec Take Wing With Tecfidera? [Published Seeking Alpha - 22 hours ago]
Interfering with interferon -- ScienceDaily [Published DailyMe.Com - Jul 29 2014]
CHI to Host Immunogenicity and Bioassay Summit ... [Published Prlog - Jul 29 2014]
New study identifies potential alternatives to ... [Published Pharma Letter - Jul 29 2014]
Phase 2 COSMOS study results published in The L... [Published European Pharmaceutical Review - Jul 29 2014]
New combination of pills curing hepatitis C pat... [Published Yahoo! India - Jul 29 2014]
A Treatment Revolution is Underway: All-Oral Th... [Published KSWT13 - Jul 29 2014]
Clearing up debris to help repair [Published Multiple Sclerosis Research - Jul 29 2014]
Illinois Medicaid restricts who can get 'game-c... [Published Crains ChicagoBusiness - Jul 29 2014]
Hepatitis C Therapeutics Market - Global Indust... [Published MyNewsDesk - Jul 29 2014]
3D Hepatitis C Combo Effective in HIV Patients [Published EverydayHealth.com - Jul 29 2014]
Today in Science: GLV Daily Digest for July 28,... [Published The Guardian Express - Jul 29 2014]
Interferon regulatory factor (IRF) 3 is critica... [Published 7thSpace - Jul 29 2014]
Devolution woes: On World Hepatitis Day, no tre... [Published The Express Tribune - Jul 28 2014]
Simeprevir/Sofosbuvir Combo Provides Sustained ... [Published P&T Community - Jul 28 2014]
New therapies for HCV create better alternative... [Published Orthopedics Today - Jul 28 2014]
Viral load decreased in patients with HCV after... [Published Orthopedics Today - Jul 28 2014]
Gilead: Does It Pass The Trial As A Long-Term I... [Published Seeking Alpha - Jul 28 2014]
COSMOS Results Published on World Hepatitis Day [Published Drug Discovery and Development - Jul 28 2014]
New pill regimens published in The Lancet cure... [Published EurekAlert! - Jul 28 2014]
Medivir AB: Phase II COSMOS Study Results Publi... [Published BioSpace - Jul 28 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clearing up debris to help repair [Published Multiple Sclerosis Research - Jul 29 2014]
Rajbhandari L, Tegenge MA, Shrestha S, Ganesh Kumar N, Malik A, Mithal A, Hosmane S, Venkatesan A.  Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons. Glia. 2014 Jul 8. doi: 10.1002/glia.22719. [Epub ahead of print]Microglia ...
Canada: Will BC cover pricey Hep C 'miracle' tr... [Published H5N1 - Jul 28 2014]
It's World Hepatitis Day, and The Tyee has a timely article by Pauline Holdsworth: Will BC Cover Pricey Hep C 'Miracle' Treatment? Excerpt:Hepatitis C patients in B.C. are waiting to hear whether the province will cover new drugs doctors say represent ...
[Articles] Simeprevir plus sofosbuvir, with or ... [Published The Lancet online - Jul 28 2014]
Combined simeprevir and sofosbuvir was efficacious and well tolerated. ...
Q&A: The new $84,000 hepatitis C drug [Published Ezra Klein - Jul 25 2014]
What is hepatitis C? It’s a long-term liver illness that can last for life, and the most severe cases could lead to cirrhosis or liver cancer. Anywhere between 75 percent and 85 percent of people who contract the virus develop a chronic condition. ...
Why Sovaldi took off: Previous treatments were ... [Published Ezra Klein - Jul 25 2014]
  Gilead Sciences president and chief operating officer John Milligan (Victor J. Blue/Bloomberg) In a  story  Thursday, I dove into the societal implications of the new $84,000 hepatitis C treatment. There's one part I want to expand upon further: ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Hemispherx Biopharma and Bioclones Join Forces ... [Published GlobeNewswire: Acquisitions News - Jul 08 2014]
Simeprevir has now been approved in Russia [Published GlobeNewswire: Acquisitions News - Mar 24 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.